Document is current

Bender Ignacio, Rachel A.

Goldman, Jason D.

Magaret, Amalia S.

Selke, Stacy

Huang, Meei-Li

Gantt, Soren

Johnston, Christine

Phipps, Warren T.

Schiffer, Joshua T.

Zuckerman, Richard A.

McClelland, R. Scott

Celum, Connie

Corey, Larry

Wald, Anna

Casper, Corey

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (T32-AI-007140)

National Institute of Allergy and Infectious Diseases (K23-AI-054162)

National Institute of Allergy and Infectious Diseases (K24-AI-071113)

National Institute of Allergy and Infectious Diseases (P01-AI-030731)

National Institute of Allergy and Infectious Diseases (R37-AI-042528)

National Cancer Institute (T32-CA-080416)

National Cancer Institute (K24-AI-071113)

National Cancer Institute (P30-CA-015704)

National Cancer Institute (R01-CA-086795)

GlaxoSmithKline (Valacyclovir study)

Center for AIDS Research, University of Washington (P30-AI-027757)

Center for AIDS Research, University of Washington (P30-AI-027757)

Fred Hutchinson Cancer Research Center (Early Detection Initiative)

AIDS Clinical Trials Group (U01-AI-038858)

Text and Data Mining valid from 2016-02-10

Version of Record valid from 2016-02-10